Avanish Vellanki - 02 Feb 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Role
President and CEO, Director
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Avanish Vellanki
Issuer symbol
N/A
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 15:30:19 UTC
Next filing
15 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +182,300 $0.000000 182,300 02 Feb 2022 Common Stock 182,300 $8.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 182,300 shares of the Issuer's common stock, one quarter of which will vest on February 2, 2023, with the remaining three quarters vesting in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to the Issuer.